DDIT4 and breast cancer: However, functional studied are needed to further investigate the precise mechanisms by which the products encoded by DDIT4 hub genes mediate resistance to chemotherapy and immunotherapy and to further confirm whether these hub genes are the potential indicators of worse prognosis in breast cancer.